Here’s a question for the pharma comms leaders: when were you first told you needed to be ‘more strategic’ or ‘more commercial’?
Hands up if, back then, you didn’t have a clue what that meant in practice? I can certainly remember being in that boat.
In 2026, the challenge of working out what it really means to add value as a comms leader is still very much alive.
Check out the rest of the feature here
